Cargando…
BHLHE40 Maintains the Stemness of PαS Cells In Vitro by Targeting Zbp1 through the Wnt/β-Catenin Signaling Pathway
Primary bone mesenchymal stem cells (BMSCs) gradually lose stemness during in vitro expansion, which significantly affects the cell therapeutic effects. Here, we chose murine PαS (SCA-1(+)PDGFRα(+)CD45(−)TER119(−)) cells as representative of BMSCs and aimed to explore the premium culture conditions...
Autores principales: | Hu, Menglong, Tian, Yueming, Liu, Xuenan, Guo, Qian, Lu, Dazhuang, Wang, Xu, Lv, Longwei, Zhang, Xiao, Liu, Yunsong, Zhou, Yongsheng, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452820/ https://www.ncbi.nlm.nih.gov/pubmed/37626688 http://dx.doi.org/10.3390/biomedicines11082190 |
Ejemplares similares
-
ZIM1 Combined with Hydrogel Inhibits Senescence of Primary PαS Cells during In Vitro Expansion
por: Tian, Yueming, et al.
Publicado: (2023) -
The PCK2-glycolysis axis assists three-dimensional-stiffness maintaining stem cell osteogenesis
por: Li, Zheng, et al.
Publicado: (2022) -
Bhlhe40: Gatekeeper of the GC
por: Nutt, Stephen L., et al.
Publicado: (2021) -
DUSP5 promotes osteogenic differentiation through SCP1/2‐dependent phosphorylation of SMAD1
por: Liu, Xuejiao, et al.
Publicado: (2021) -
Non-circadian aspects of BHLHE40 cellular function in cancer
por: Kiss, Zsofia, et al.
Publicado: (2020)